Furthermore, germline heterozygous mutations in TP53 cause the rare cancer predisposing Li-Fraumeni syndrome [3, 4] and 100% of mice lacking Trp53 develop tumours, primarily lymphomas or sarcomas highlighting the pivotal role of TP53 as a tumour suppressor [5–7]. This evidence concerns the gene TP53 and Li-Fraumeni syndrome.